Amarin Corp Plcuk (AMRN) Intangibles (2012 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Intangibles of $32.1 million for Q2 2026, down 3.34% year-over-year from $33.2 million in Q2 2025, and little changed quarter-over-quarter from $32.1 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Intangibles (2012 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Intangibles for 15 consecutive years, with $32.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Intangibles fell 3.34% year-over-year to $32.1 million; the TTM figure through Jun 2026 stood at $32.1 million (down 3.34% YoY), while the FY2025 annual figure was $32.1 million, down 3.34% from the prior year.
- Intangibles was little changed at $32.1 million in Q2 2026 per AMRN's latest filing, from $32.1 million in the prior quarter.
- Across five years, Intangibles topped out at $33.2 million in Q4 2023 and bottomed at $32.1 million in Q1 2022.
- Historically, Intangibles has averaged $32.7 million across 5 years, with a median of $32.9 million in 2022.
- Annual changes were most pronounced in 2022 — Intangibles rose 2.43% — and 2025, when it declined 3.34%.
- Amarin Corp Plc\Uk's Intangibles stood at $32.9 million in 2022, then increased by 1.0% to $33.2 million in 2023, then changed by 0.0% to $33.2 million in 2024, then fell by 3.34% to $32.1 million in 2025, then changed by 0.0% to $32.1 million in 2026.
- Business Quant data shows AMRN's Intangibles at $32.1 million in Q2 2026, $32.1 million in Q1 2026, and $32.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 22.54 Bn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | 32.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.08 Mn |
| Mar 31, 2026 | 32.08 Mn |
| Dec 31, 2025 | 32.08 Mn |
| Sep 30, 2025 | 33.19 Mn |
| Jun 30, 2025 | 33.19 Mn |
| Mar 31, 2025 | 33.19 Mn |
| Dec 31, 2024 | 33.19 Mn |
| Sep 30, 2024 | 33.19 Mn |
| Jun 30, 2024 | 33.19 Mn |
| Mar 31, 2024 | 33.19 Mn |
| Dec 31, 2023 | 33.19 Mn |
| Sep 30, 2023 | 32.86 Mn |
| Jun 30, 2023 | 32.86 Mn |
| Mar 31, 2023 | 32.86 Mn |
| Dec 31, 2022 | 32.86 Mn |
| Sep 30, 2022 | 32.08 Mn |
| Jun 30, 2022 | 32.08 Mn |
| Mar 31, 2022 | 32.08 Mn |
| Dec 31, 2021 | 32.08 Mn |
| Sep 30, 2021 | 32.08 Mn |